Lista de obras -

Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis

artículo científico publicado en 2002

EUK-134 reduces renal dysfunction and injury caused by oxidative and nitrosative stress of the kidney

artículo científico publicado en 2004

Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat.

artículo científico publicado en 2002

Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion

artículo científico publicado en 2004

FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart

scientific article published on 12 July 2011

Factors associated with increasing vascular stiffness in PD

scientific article published on 18 March 2011

Inhibitors of calpain activation (PD150606 and E-64) and renal ischemia-reperfusion injury

artículo científico publicado en 2005

Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation

artículo científico publicado en 2002

Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice

artículo científico publicado en 2003

Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton

artículo científico publicado en 2004

Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury

artículo científico publicado en 2002

Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

artículo científico publicado en 2003

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation

artículo científico publicado en 2004

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice

artículo científico publicado en 2004

The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation

artículo científico publicado en 2002

The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat.

artículo científico publicado en 2003

Lista de obras de

Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis

EUK-134 reduces renal dysfunction and injury caused by oxidative and nitrosative stress of the kidney

Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat.

Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion

FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart

Factors associated with increasing vascular stiffness in PD

Inhibitors of calpain activation (PD150606 and E-64) and renal ischemia-reperfusion injury

Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation

Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice

Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton

Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury

Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice

The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation

The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat.